Malignant peritoneal mesothelioma in patients with endometriosis

Kelly J Butnor1, Justin Rueckert1, Elizabeth N Pavlisko2

  • 1Department of Pathology and Laboratory Medicine, University of Vermont Medical Center, Burlington, Vermont, USA.

Abstract

Insights

This study reports the first cases of malignant mesothelioma (MM) in women with endometriosis. Endometriosis-associated inflammation may contribute to peritoneal MM development in rare instances.

Area of Science:

  • Gynecologic Pathology
  • Mesothelioma Research
  • Oncology

Background:

  • Endometriosis is linked to benign mesothelial proliferations like florid mesothelial hyperplasia.
  • Malignant mesothelioma (MM) and endometriosis association is previously unreported.
  • Peritoneal inclusion cysts and papillary mesothelioma have been described with endometriosis.

Purpose of the Study:

  • To describe the clinicopathological features of women diagnosed with malignant mesothelioma (MM) and endometriosis.
  • To investigate the potential link between endometriosis and the development of peritoneal MM.

Main Methods:

  • Retrospective review of surgical pathology and consultation files.
  • Inclusion of female patients diagnosed with MM, with and without endometriosis.
  • Analysis of clinicopathological data for identified cases.

Main Results:

  • Six women with peritoneal MM and endometriosis were identified (ages 29-55, median 45).
  • All cases involved peritoneal MM and endometriosis of the peritoneum and/or adnexa.
  • Median age of MM patients with endometriosis was significantly lower (44.5 years) than those without (58.0 years).

Conclusions:

  • This is the first report of malignant mesothelioma (MM) occurring in women with endometriosis.
  • MM in this context was exclusively observed in the peritoneum.
  • Chronic serosal inflammation from endometriosis may be a potential factor in rare peritoneal MM development.

Related Concept Videos

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
855
Peritoneal Dialysis I: Introduction and Procedure01:30

Peritoneal Dialysis I: Introduction and Procedure

Peritoneal dialysis (PD) is a procedure that facilitates the exchange of solutes, waste products, electrolytes, and excess fluid between the blood in the peritoneal capillaries and a dialysis solution introduced into the peritoneal cavity.Principles of Peritoneal Dialysis (PD)Diffusion: Waste products such as urea and electrolytes move from high concentrations in the blood to low concentrations in the dialysate across the peritoneal membrane. This mechanism is driven by the concentration...
3.3K
Peritoneal Dialysis III: Nursing Management01:25

Peritoneal Dialysis III: Nursing Management

Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...
889
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis01:30

Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis

Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...
537
Patient-centered Care01:13

Patient-centered Care

Patient-centered care involves delivering care beyond inpatient hospitalization. Reflective practice can enhance a patient-centered approach. Reflective practice is a process of reasoning that considers all aspects of the present situation, including practicalities, learning from personal practice, and consideration of patient needs. Patients appreciate care decisions made while considering their input. Involving the patient in their care provides the patient with a sense of contribution rather...
3.1K
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
278